Dexamethasone Ophthalmic Insert

DRUG2 trials

Sponsors

The New York Eye Surgery Center, The Cleveland Clinic

Conditions

CataractGlaucomaOcular InflammationPost-Operative InflammationPost-operative PainVitreoretinal Surgery

Phase 4

Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery

TerminatedNCT04200651

The New York Eye Surgery CenterCataract, Glaucoma

Start: 2020-01-13End: 2023-07-12Updated: 2024-01-31

Dextenza in the Post-op Management of Vitreoretinal Surgeries

RecruitingNCT04371445

The Cleveland ClinicOcular Inflammation, Post-Operative Inflammation, Post-operative Pain +1

Start: 2020-06-01End: 2026-05-01Target: 30Updated: 2026-02-10